Tapewire

Nasdaq · USD

AEHR

AEHR TEST SYSTEMS

Export transactions ↓
Tapewire entity
2640
SEC CIK
0001040470
Parsed reports
879

Last 12 months

Inside the activity.

0 purchase rows · 73 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202605
Feb 202603
Mar 202600
Apr 2026042
May 202603
Jun 202600
Jul 202601
Aug 2026018
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 15,140 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · derivative · entry 8

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,140 shares

Expires 2023-07-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 62,727 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · derivative · entry 7

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,338

Underlying: Common Stock · 62,727 shares

Expires 2026-07-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
SaleCommon Stock 80,000 $23.29 $1,862,960.00
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 6

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,847

F1 · shares: The shares were sold to cover the exercise cost and income tax payments in connection with the exercise of non-qualified stock options.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.91 to $23.90, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionCommon Stock 62,727 $1.64 $102,558.65
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 5

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 579,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionCommon Stock 19,003 $2.40 $45,607.20
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 4

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 517,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionCommon Stock 10,344 $3.93 $40,651.92
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 3

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 498,117

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionCommon Stock 15,140 $1.68 $25,435.20
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 2

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 487,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2021 Filed Nov 15, 2021 21:00 UTC
Erickson GaynDirector · President and CEO
Exercise / conversionCommon Stock 29,880 $2.10 $62,748.00
Disclosure

SEC source: 0001654954-21-012199 · section16.xml · nonDerivative · entry 1

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,633

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2021 Filed Nov 11, 2021 01:17 UTC GiftCommon Stock 809 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011983 · section16.xml · nonDerivative · entry 2

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,515

F2 · shares: The shares were donated to California Casa Foundation.

F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
November 09, 2021 Filed Nov 11, 2021 01:17 UTC GiftCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011983 · section16.xml · nonDerivative · entry 1

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,324

F1 · shares: The shares were gifted to the Reporting Person's son.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:15 UTC Exercise / conversionIncentive Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001654954-21-011796 · section16.xml · derivative · entry 3

HENDRICKSON DAVID S · CIK 0001244094 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:15 UTC SaleCommon Stock 25,000 $25.08 $627,000.00
Disclosure

SEC source: 0001654954-21-011796 · section16.xml · nonDerivative · entry 2

HENDRICKSON DAVID S · CIK 0001244094 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,402

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.5718 to $25.5069, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:15 UTC Exercise / conversionCommon Stock 25,000 $2.10 $52,500.00
Disclosure

SEC source: 0001654954-21-011796 · section16.xml · nonDerivative · entry 1

HENDRICKSON DAVID S · CIK 0001244094 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:13 UTC
Erickson GaynDirector · President and CEO
SaleCommon Stock 100,000 $25.75 $2,575,000.00
Disclosure

SEC source: 0001654954-21-011794 · section16.xml · nonDerivative · entry 1

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,753

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $26.655, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
November 03, 2021 Filed Nov 5, 2021 21:00 UTC SaleCommon Stock 25,000 $24.91 $622,750.00
Disclosure

SEC source: 0001654954-21-011742 · section16.xml · nonDerivative · entry 1

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 597,578

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.90 to $25.00, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 28, 2021 Filed Nov 1, 2021 18:33 UTC SaleCommon Stock 11,381 $21.50 $244,691.50
Disclosure

SEC source: 0001654954-21-011590 · section16.xml · nonDerivative · entry 1

OLIPHANT LAURA · CIK 0001783244 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 21,010

F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 28, 2021 Filed Nov 1, 2021 18:33 UTC SaleCommon Stock 50,000 $20.77 $1,038,500.00
Disclosure

SEC source: 0001654954-21-011589 · section16.xml · nonDerivative · entry 1

SCOTT GEOFFREY GATES · CIK 0001824121 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 190,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.53 to $21.15, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Read SEC document
October 26, 2021 Filed Oct 27, 2021 22:15 UTC GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011416 · section16.xml · nonDerivative · entry 2

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 622,578

F2 · shares: The shares were gifted to the Reporting Person's daughter.

F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 00:23 UTC
RICHMOND DONALD P. IIVP of Engineering
SaleCommon Stock 26,041 $20.70 $538,994.01
Disclosure

SEC source: 0001654954-21-011418 · section16.xml · nonDerivative · entry 1

RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,116

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $20.77, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 25, 2021 Filed Oct 27, 2021 22:15 UTC GiftCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011416 · section16.xml · nonDerivative · entry 1

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 632,578

F1 · shares: The shares were gifted to the Reporting Person's significant other.

Read SEC document
October 21, 2021 Filed Oct 25, 2021 21:00 UTC SaleCommon Stock 10,000 $21.50 $215,000.00
Disclosure

SEC source: 0001654954-21-011329 · section16.xml · nonDerivative · entry 1

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,324

F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 19, 2021 Filed Oct 20, 2021 21:25 UTC GrantCommon Stock 3,023 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011233 · section16.xml · nonDerivative · entry 1

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 652,578

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 19, 2021 Filed Oct 21, 2021 01:00 UTC GrantCommon Stock 2,015 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011243 · section16.xml · nonDerivative · entry 1

ROSATI MARIO M · CIK 0001197808 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 60,196

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

F3 · ownership.nature: Shares held by Mario M. Rosati and Danelle Storm Rosati, Trustees of the Rosati Family Trust dated May 23, 1997.

Read SEC document
October 19, 2021 Filed Oct 21, 2021 00:30 UTC GrantCommon Stock 2,015 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011241 · section16.xml · nonDerivative · entry 1

DANESH FARIBA · CIK 0001228855 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 6,708

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 19, 2021 Filed Oct 21, 2021 00:27 UTC GrantCommon Stock 2,015 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011239 · section16.xml · nonDerivative · entry 1

SCOTT GEOFFREY GATES · CIK 0001824121 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 63,524

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 19, 2021 Filed Oct 20, 2021 21:34 UTC GrantCommon Stock 2,015 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011237 · section16.xml · nonDerivative · entry 1

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,324

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 19, 2021 Filed Oct 20, 2021 21:26 UTC GrantCommon Stock 2,015 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-011235 · section16.xml · nonDerivative · entry 1

OLIPHANT LAURA · CIK 0001783244 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 32,391

F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 21:07 UTC SaleCommon Stock 9,400 $21.05 $197,903.84
Disclosure

SEC source: 0001654954-21-011187 · section16.xml · nonDerivative · entry 2

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 649,555

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.1565, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 21:01 UTC
ROGERS VERNONExec. VP Sales and Marketing
Tax withholdingCommon Stock 433 $20.69 $8,958.77
Disclosure

SEC source: 0001654954-21-011158 · section16.xml · nonDerivative · entry 2

ROGERS VERNON · CIK 0001756642 · Exec. VP Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,352

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 21:01 UTC
RICHMOND DONALD P. IIVP of Engineering
Tax withholdingCommon Stock 404 $20.69 $8,358.76
Disclosure

SEC source: 0001654954-21-011157 · section16.xml · nonDerivative · entry 2

RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,157

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 21:01 UTC
Erickson GaynDirector · President and CEO
Tax withholdingCommon Stock 2,391 $20.69 $49,469.79
Disclosure

SEC source: 0001654954-21-011154 · section16.xml · nonDerivative · entry 2

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 542,753

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 21:01 UTC Tax withholdingCommon Stock 208 $20.69 $4,303.52
Disclosure

SEC source: 0001654954-21-011156 · section16.xml · nonDerivative · entry 2

HENDRICKSON DAVID S · CIK 0001244094 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,402

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 21:01 UTC
SPINK KENNETH B.VP of Finance and CFO
Tax withholdingCommon Stock 1,122 $20.69 $23,214.18
Disclosure

SEC source: 0001654954-21-011155 · section16.xml · nonDerivative · entry 2

SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,466

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 21:07 UTC SaleCommon Stock 15,600 $21.02 $327,865.20
Disclosure

SEC source: 0001654954-21-011187 · section16.xml · nonDerivative · entry 1

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 658,955

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.15, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC
Brannan Michael A.V.P. of Operations
Tax withholdingCommon Stock 230 $20.46 $4,705.80
Disclosure

SEC source: 0001654954-21-011159 · section16.xml · nonDerivative · entry 1

Brannan Michael A. · CIK 0001807248 · V.P. of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,721

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC
ROGERS VERNONExec. VP Sales and Marketing
Tax withholdingCommon Stock 233 $20.46 $4,767.18
Disclosure

SEC source: 0001654954-21-011158 · section16.xml · nonDerivative · entry 1

ROGERS VERNON · CIK 0001756642 · Exec. VP Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,785

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC
RICHMOND DONALD P. IIVP of Engineering
Tax withholdingCommon Stock 239 $20.46 $4,889.94
Disclosure

SEC source: 0001654954-21-011157 · section16.xml · nonDerivative · entry 1

RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,561

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC
Erickson GaynDirector · President and CEO
Tax withholdingCommon Stock 1,515 $20.46 $30,996.90
Disclosure

SEC source: 0001654954-21-011154 · section16.xml · nonDerivative · entry 1

Erickson Gayn · CIK 0001364097 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 545,144

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC Tax withholdingCommon Stock 116 $20.46 $2,373.36
Disclosure

SEC source: 0001654954-21-011156 · section16.xml · nonDerivative · entry 1

HENDRICKSON DAVID S · CIK 0001244094 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,610

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:01 UTC
SPINK KENNETH B.VP of Finance and CFO
Tax withholdingCommon Stock 729 $20.46 $14,915.34
Disclosure

SEC source: 0001654954-21-011155 · section16.xml · nonDerivative · entry 1

SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,588

F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC SaleCommon Stock 50,000 $21.11 $1,055,500.00
Disclosure

SEC source: 0001654954-21-011153 · section16.xml · nonDerivative · entry 1

SCOTT GEOFFREY GATES · CIK 0001824121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,594

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.79 to $21.33, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 18,219 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · derivative · entry 6

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,219 shares

Expires 2021-10-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · derivative · entry 5

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2021-10-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC SaleCommon Stock 2,500 $20.45 $51,125.25
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · nonDerivative · entry 4

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,309

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC SaleCommon Stock 2,500 $20.47 $51,162.50
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · nonDerivative · entry 3

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,809

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC Exercise / conversionCommon Stock 18,219 $2.06 $37,585.80
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · nonDerivative · entry 2

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,309

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 21:00 UTC Exercise / conversionCommon Stock 10,000 $2.06 $20,630.00
Disclosure

SEC source: 0001654954-21-011152 · section16.xml · nonDerivative · entry 1

SLAYEN HOWARD T · CIK 0001203324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,090

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 12, 2021 Filed Oct 13, 2021 21:00 UTC
Brannan Michael A.V.P. of Operations
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 14,125 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001654954-21-011064 · section16.xml · derivative · entry 5

Brannan Michael A. · CIK 0001807248 · V.P. of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,875

Underlying: Common Stock · 14,125 shares

Expires 2027-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Read SEC document
October 12, 2021 Filed Oct 13, 2021 21:00 UTC
Brannan Michael A.V.P. of Operations
Exercise / conversionCommon Stock 14,125 $1.22 $17,232.50
Disclosure

SEC source: 0001654954-21-011064 · section16.xml · nonDerivative · entry 3

Brannan Michael A. · CIK 0001807248 · V.P. of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units.

Read SEC document
October 11, 2021 Filed Oct 12, 2021 21:02 UTC SaleCommon Stock 24,000 $19.93 $478,320.00
Disclosure

SEC source: 0001654954-21-011005 · section16.xml · nonDerivative · entry 2

POSEDEL RHEA J · CIK 0001055117 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 674,555

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.10, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.